Research Report
The 2024 State of Patient Access Annual Report
We surveyed 309 pharmaceutical and biotech leaders.
In this report, the authors highlight three key takeaways from the survey.
Plus, they weigh in on what these trends mean for manufacturers.
The Dedham Group & MMIT’s first-annual industry survey sheds light on the current and future patient access landscape—and how pharma manufacturers can get innovative products from pipeline to patient.